Integrating structure to protein-protein interaction networks that drive metastasis to brain and lung in breast cancer

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Billur Engin, H ^a   Guney, Emre ^b   Keskin, Ozlem ^a   Oliva, Baldo ^b   Gursoy, Attila ^a  

^a KOÇ UNIVERSITY   (Turkey)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN BINDING;

BRAIN TUMOR; BREAST TUMOR; CHEMICAL STRUCTURE; CHEMISTRY; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; SECONDARY;

BRAIN NEOPLASMS; BREAST NEOPLASMS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MODELS, MOLECULAR; NEOPLASM METASTASIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEINS;

EID: 84894309512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081035     Document Type: Article

References (74)

1. Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM et al. (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30: 4500-4514. doi:10.1038/emboj.2011.312. PubMed: 21873975.
2. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P et al. (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22: 2865-2872. doi:10.1200/JCO.2004.12.149. PubMed: 15254054. (Pubitemid 41079905)
3. DeSantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics, 2011. CA Cancer J Clin 61: 409-418. PubMed: 21969133.
4. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524. doi:10.1038/nature03799. PubMed: 16049480. (Pubitemid 41112921)
5. Bild AH, Yao G, Chang JT, Wang Q, Potti A et al. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357. doi:10.1038/nature04296. PubMed: 16273092. (Pubitemid 43128862)
6. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549. doi:10.1016/S1535-6108(03)00132-6. PubMed: 12842083. (Pubitemid 36808649)
7. Mehrotra J, Vali M, McVeigh M, Kominsky SL, Fackler MJ et al. (2004) Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res 10: 3104-3109. doi:10.1158/1078-0432.CCR- 03-0118. PubMed: 15131050. (Pubitemid 38619690)
8. Müller A, Homey B, Soto H, Ge N, Catron D et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56. doi:10.1038/35065016. PubMed: 11242036. (Pubitemid 32225831)
9. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L et al. (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-971. PubMed: 15705897. (Pubitemid 40216458)
10. Brown DM, Ruoslahti E (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365-374. doi:10.1016/S1535-6108(04)00079-0. PubMed: 15093543. (Pubitemid 38482072)
11. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG et al. (2009) WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51-62. doi:10.1016/j.cell.2009.04.030. PubMed: 19576624.
12. Weigelt B, Peterse JL, van 't Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602. doi:10.1038/nrc1670. PubMed: 16056258. (Pubitemid 41081385)
13. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459: 1005-1009. doi:10.1038/nature08021. PubMed: 19421193.
14. Van Heyningen V, Yeyati PL (2004) Mechanisms of non-Mendelian inheritance in genetic disease. Human molecular genetics 13 Spec No 2: R225-233
15. Ergün A, Lawrence CA, Kohanski MA, Brennan TA, Collins JJ (2007) A network biology approach to prostate cancer. Mol Syst Biol 3: 82. PubMed: 17299418.
16. Wu X, Jiang R, Zhang MQ, Li S (2008) Network-based global inference of human disease genes. Mol Syst Biol 4: 189. PubMed: 18463613.
17. Lee I, Lehner B, Vavouri T, Shin J, Fraser AG et al. (2010) Predicting genetic modifier loci using functional gene networks. Genome Res 20: 1143-1153. doi:10.1101/gr.102749.109. PubMed: 20538624.
18. Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18: 644-652. doi:10.1101/gr.071852.107. PubMed: 18381899. (Pubitemid 351482789)
19. Chuang HY, Lee E, Liu YT, Lee D, Ideker T (2007) Network-based classification of breast cancer metastasis. Mol Syst Biol 3: 140. PubMed: 17940530.
20. Kann MG (2007) Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform 8: 333-346. doi:10.1093/bib/bbm031. PubMed: 17638813.
21. Wang X, Wei X, Thijssen B, Das J, Lipkin SM et al. (2012) Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30: 159-164. doi:10.1038/nbt.2106. PubMed: 22252508.
22. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN et al. (2000) The Protein Data Bank. Nucleic Acids Res 28: 235-242. doi:10.1093/nar/28.1.235. PubMed: 10592235. (Pubitemid 30047768)
23. David A, Razali R, Wass MN, Sternberg MJ (2012) Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs. Hum Mutat 33: 359-363. doi:10.1002/humu.21656. PubMed: 22072597.
24. Aloy P, Russell RB (2002) Interrogating protein interaction networks through structural biology. Proc Natl Acad Sci U S A 99: 5896-5901. doi:10.1073/pnas.092147999. PubMed: 11972061. (Pubitemid 34493236)
25. Kiel C, Beltrao P, Serrano L (2008) Analyzing protein interaction networks using structural information. Annu Rev Biochem 77: 415-441. doi:10.1146/annurev.biochem.77.062706.133317. PubMed: 18304007.
26. Xie L, Li J, Bourne PE (2009) Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors. PLoS Comput Biol 5: e1000387. PubMed: 19436720.
27. Haupt VJ, Schroeder M (2011) Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform 12: 312-326. doi:10.1093/bib/bbr011. PubMed: 21441562.
28. Pérot S, Sperandio O, Miteva MA, Camproux AC, Villoutreix BO (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 15: 656-667. doi:10.1016/j.drudis. 2010.05.015. PubMed: 20685398.
29. Engin HB, Keskin O, Nussinov R, Gursoy A (2012) A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model 52: 2273-2286. doi:10.1021/ci300072q. PubMed: 22817115.
30. Engin HB, Gursoy A, Nussinov R, Keskin O (2013) Network-Based Strategies Can Help Mono- and Poly-pharmacology Drug Discovery: A Systems Biology View. Curr Pharm Des: ([MedlinePgn:]) PubMed: 23713773.
31. Garcia-Garcia J, Guney E, Aragues R, Planas-Iglesias J, Oliva B (2010) Biana: a software framework for compiling biological interactions and analyzing networks. BMC Bioinformatics 11: 56. doi:10.1186/1471-2105-11-56. PubMed: 20105306.
32. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU et al. (2004) The Database of Interacting Proteins: 2004 update. Nucleic Acids Res 32: D449-D451. doi:10.1093/nar/gkh409. PubMed: 14681454. (Pubitemid 38081696)
33. Pagel P, Kovac S, Oesterheld M, Brauner B, Dunger-Kaltenbach I et al. (2005) The MIPS mammalian protein-protein interaction database. Bioinformatics 21: 832-834. doi:10.1093/bioinformatics/bti115. PubMed: 15531608. (Pubitemid 40439425)
34. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S et al. (2009) Human Protein Reference Database - 2009 update. Nucleic Acids Res 37: D767-D772. doi:10.1093/nar/gkn892. PubMed: 18988627.
35. Bader GD, Betel D, Hogue CW (2003) BIND: the Biomolecular Interaction Network. Database - Nucleic Acids Research 31: 248-250. doi:10.1093/nar/gkg056. (Pubitemid 36150376)
36. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F et al. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Res 40: D841-D846. doi:10.1093/nar/gkr1088. PubMed: 22121220.
37. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M et al. (2012) MINT, the molecular interaction database: 2012 update. Nucleic Acids Res 40: D857-D861. doi:10.1093/nar/gkr930. PubMed: 22096227.
38. Stark C, Breitkreutz BJ, Chatr-Aryamontri A, Boucher L, Oughtred R et al. (2011) The BioGRID Interaction Database: 2011 update. Nucleic Acids Res 39: D698-D704. doi:10.1093/nar/gkq1116. PubMed: 21071413.
39. Guney E, Oliva B (2012) Exploiting protein-protein interaction networks for genome-wide disease-gene prioritization. PLOS ONE 7: e43557. doi:10.1371/journal.pone.0043557. PubMed: 23028459.
40. Keya De Mukhopadhyay AGE, Hinck Andrew P., Yoon Kihoon, Cornell John E., Yu Lan, Liu Zhao, Yang Junhua, and LuZhe Sun (2012)
41. UniProt Consortium (2013) Update on activities at the Universal Protein Resource (UniProt) in 2013. Nucleic Acids Res 41: D43-D47. doi:10.1093/nar/ gks902. PubMed: 23161681.
42. Liu X, Yu X, Zack DJ, Zhu H, Qian J (2008) TiGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics 9: 271. doi:10.1186/1471-2105-9-271. PubMed: 18541026.
43. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M et al. (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25: 1091-1093. doi:10.1093/ bioinformatics/btp101. PubMed: 19237447.
44. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432. doi:10.1093/bioinformatics/btq675. PubMed: 21149340.
45. Keskin O, Nussinov R, Gursoy A (2008) PRISM: protein-protein interaction prediction by structural matching. Methods Mol Biol 484: 505-521. doi:10.1007/978-1-59745-398-1-30. PubMed: 18592198.
46. Ogmen U, Keskin O, Aytuna AS, Nussinov R, Gursoy A (2005) PRISM: protein interactions by structural matching. Nucleic Acids Res 33: W331-W336. doi:10.1093/nar/gki585. PubMed: 15991339. (Pubitemid 44529938)
47. Tuncbag N, Gursoy A, Nussinov R, Keskin O (2011) Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using. Prism - Nature Protocols 6: 1341-1354. doi:10.1038/nprot.2011.367.
48. Kar G, Keskin O, Nussinov R, Gursoy A (2012) Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs. J Proteome Res 11: 1196-1207. doi:10.1021/pr2009143. PubMed: 22149024.
49. Acuner Ozbabacan SE, Keskin O, Nussinov R, Gursoy A (2012) Enriching the human apoptosis pathway by predicting the structures of protein-protein complexes. J Struct Biol 179: 338-346. doi:10.1016/j.jsb.2012.02.002. PubMed: 22349545.
50. Tuncbag N, Keskin O, Nussinov R, Gursoy A (2012) Fast and accurate modeling of protein-protein interactions by combining template-interface-based docking with flexible refinement. Proteins 80: 1239-1249. doi:10.1002/prot. 24022. PubMed: 22275112.
51. Zhang Y, Skolnick J (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 33: 2302-2309. doi:10.1093/nar/gki524. PubMed: 15849316. (Pubitemid 41439897)
52. Team RC (2013) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
53. Kumar R, Nanduri B (2010) HPIDB - a unified resource for host-pathogen interactions. BMC Bioinformatics 11 Suppl 6: S16. doi:10.1186/1471-2105-11-S1- S16. PubMed: 20946599.
54. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39: D945-D950. doi:10.1093/nar/gkq929. PubMed: 20952405.
55. Martin AC (2005) Mapping PDB chains to UniProtKB entries. Bioinformatics 21: 4297-4301. doi:10.1093/bioinformatics/bti694. PubMed: 16188924.
56. Hubbard SJ, Thornton JM (1993) naccess. Department of Biochemistry and Molecular Biology, University College London.
57. Lee B, Richards FM (1971) The interpretation of protein structures: estimation of static accessibility. J Mol Biol 55: 379-400. doi:10.1016/0022- 2836(71)90324-X. PubMed: 5551392.
58. Tuncbag N, Gursoy A, Keskin O (2009) Identification of computational hot spots in protein interfaces: combining solvent accessibility and inter-residue potentials improves the accuracy. Bioinformatics 25: 1513-1520. doi:10.1093/bioinformatics/btp240. PubMed: 19357097.
59. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 27-38. 8744570.
60. Mao X, Cai T, Olyarchuk JG, Wei L (2005) Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics 21: 3787-3793. doi:10.1093/bioinformatics/bti430. PubMed: 15817693. (Pubitemid 41535528)
61. Zetter BR (1993) Adhesion molecules in tumor metastasis. Semin Cancer Biol 4: 219-229. PubMed: 8400144.
62. Bendas G, Borsig L (2012) Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. International journal of cell biology 2012: 676731
63. Walter F. PB (2003) Medical Physiology: A Cellular And Molecular Approach; Elsevier/Saunders, editor
64. Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376. PubMed: 12663862. (Pubitemid 36382891)
65. Sordat B PJ-C, Weiss L (1990) Is there a common definition for invasiveness? Invasion Metastasis 10: 178-192
66. Orozco E, Benitez-Bibriesca L, Hernandez R (1994) Invasion and metastasis mechanisms in Entamoeba histolytica and cancer cells. Some common cellular and molecular features. Mutat Res 305: 229-239. doi:10.1016/0027-5107(94)90243-7. PubMed: 7510034. (Pubitemid 24082899)
67. Leroy A, Mareel M, De Bruyne G, Bailey G, Nelis H (1994) Metastasis of Entamoeba histolytica compared to colon cancer: one more step in invasion. Invasion Metastasis 14: 177-191. PubMed: 7657511.
68. Haile S (2008) Cancer metastasis and in vivo dissemination of tissued-welling pathogens: extrapolation of mechanisms and exchange of treatment strategies thereof. Med Hypotheses 70: 375-377. doi:10.1016/j.mehy.2007.04.042. PubMed: 17826000.
69. Liu K-J, Shih N-Y (2007) The Role of Enolase in Tissue Invasion and Metastasis of Pathogens and Tumor; Cells J Cancer Mol 3: 45-48
70. MacDonald TJ, Brown KM, LaFleur B, Peterson K, Lawlor C et al. (2001) Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29: 143-152. doi:10.1038/ng731. PubMed: 11544480. (Pubitemid 32952650)
71. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW et al. (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284: 31-53. doi:10.1016/S0014-4827(02)00098-8. PubMed: 12648464. (Pubitemid 36331965)
72. Sillitoe I, Cuff AL, Dessailly BH, Dawson NL, Furnham N et al. (2013) New functional families (FunFams) in CATH to improve the mapping of conserved functional sites to 3D structures. Nucleic Acids Res 41: D490-D498. doi:10.1093/nar/gks1211. PubMed: 23203873.
73. Shin SY, Yokoyama T, Takenouchi T, Munekata E (2003) The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF). J Pept Sci 9: 244-250. PubMed: 12725245. (Pubitemid 36869588)
74. Sato K, Nakamura T, Mizuguchi M, Miura K, Tada M et al. (2003) Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity. FEBS Lett 553: 232-238. doi:10.1016/S0014-5793(03)01005-6. PubMed: 14572630. (Pubitemid 37315610)